Articles

10.4244/EIJV9I5A90 Sep 27, 2013
Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y, Zhong S-L
free

10.4244/EIJV9I5A91 Sep 27, 2013
Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique
Nijhoff F, Agostoni P, Samim M, Ramjankhan F, Kluin J, Doevendans P, Stella P
free

10.4244/EIJV9I5A93 Sep 27, 2013
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I, Dubois C, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger J, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S
free

10.4244/EIJV9I5A94 Sep 27, 2013
A new methodology for accurate 3-dimensional coronary artery reconstruction using routine intravascular ultrasound and angiographic data: implications for widespread assessment of endothelial shear stress in humans
Bourantas C, Papafaklis M, Athanasiou L, Kalatzis F, Naka K, Siogkas P, Takahashi S, Saito S, Fotiadis D, Feldman C, Stone P, Michalis L
free

10.4244/EIJV9I5A96 Sep 27, 2013
Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography
Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S
free

10.4244/EIJV9I5A97 Sep 27, 2013
No indication for an unexpected high rate of coronary artery aneurysms after angioplasty with drug-coated balloons
Kleber F-X, Schulz A, Bonaventura K, Fengler A
free

10.4244/EIJV9I5A98 Sep 27, 2013
Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial
Waksman R, Serra A, Loh J, Malik F, Torguson R, Stahnke S, Von Strandmann R, Rodríguez A
free

10.4244/EIJV9I5A99 Sep 27, 2013
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Unverdorben M, Kleber F-X, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Borger MA, Degenhardt R, Scheller B
free

10.4244/EIJV9I5A100 Sep 27, 2013
Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale
Freixa X, Ibrahim R, Chan J, Garceau P, Dore A, Marcotte F, Mercier L-A, Pierre-Mongeon F, Basmadjian A, Khairy P, Asgar A
free

10.4244/EIJV9I5A101 Sep 27, 2013
Emergency transseptal transcatheter mitral valve-in-valve implantation
Fassa A-A, Himbert D, Brochet E, Alkhoder S, Al-Attar N, Brun P-Y, Wolff M, Nataf P, Vahanian A
free

10.4244/EIJV9I5A102 Sep 27, 2013
MitraClip® via direct right atrial access in case of a missing inferior vena cava
Frerker C, Meincke F, Seibert H-P, Alessandrini H, Kreidel F, Caspary M, Busse C, Schäfer U, Kuck K
free

10.4244/EIJV9I5A103 Sep 27, 2013
Tools and Techniques - Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System
Amrane H, Porta F, Van Boven A, Hofma S, Head S, Kappetein A
free

10.4244/EIJV9I5A104 Sep 27, 2013
How should I treat severe paravalvular leakage after TAVI?
Reinthaler M, Empen K, Busch M, Konemann R, Ince H, Felix S
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved